All Stories

  1. Expanding the Phenotypic Spectrum of TRAF7-Related Cardiac, Facial, and Digital Anomalies With Developmental Delay: Report of 11 New Cases and Literature Review
  2. Evolutionary and functional analyses of LRP5 in archaic and extant modern humans
  3. Subcellular localisation of truncated MAGEL2 proteins: insight into the molecular pathology of Schaaf-Yang syndrome
  4. A crowdsourcing database for the copy-number variation of the Spanish population
  5. Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2
  6. Clinical description and genetic analysis of a novel familial skeletal dysplasia characterized by high bone mass and lucent bone lesions
  7. On the association between Chiari malformation type 1, bone mineral density and bone related genes
  8. Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
  9. CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts
  10. Genetic Analysis in a Familial Case With High Bone Mineral Density Suggests Additive Effects at Two Loci
  11. CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative
  12. Fifteen years of enzyme replacement therapy for mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome): a case report
  13. Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment
  14. Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis
  15. Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques
  16. A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders
  17. Human oocyte meiotic maturation is associated with a specific profile of alternatively spliced transcript isoforms
  18. Functional Analyses of Four CYP1A1 Missense Mutations Present in Patients with Atypical Femoral Fractures
  19. Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease
  20. De Novo PORCN and ZIC2 Mutations in a Highly Consanguineous Family
  21. Genetics and Genomics of SOST: Functional Analysis of Variants and Genomic Regulation in Osteoblasts
  22. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling
  23. Functional Assessment of Coding and Regulatory Variants From the DKK1 Locus
  24. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches
  25. CSVS, a crowdsourcing database of the Spanish population genetic variability
  26. Improved Diagnosis of Rare Disease Patients through Systematic Detection of Runs of Homozygosity
  27. Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece
  28. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7
  29. Effect of the Tumor Suppressor miR-320a on Viability and Functionality of Human Osteosarcoma Cell Lines Compared to Primary Osteoblasts
  30. Neuronal and Astrocytic Differentiation from Sanfilippo C Syndrome iPSCs for Disease Modeling and Drug Development
  31. Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum
  32. Generation of two NAGLU-mutated homozygous cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B syndrome
  33. Mutational spectrum by phenotype: panel‐based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café‐au‐lait macules
  34. Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome
  35. Extending the phenotypic spectrum of Bohring‐Opitz syndrome: Mild case confirmed by functional studies
  36. Functional characterization of the C7ORF76 genomic region, a prominent GWAS signal for osteoporosis in 7q21.3
  37. Bone development and remodeling in metabolic disorders
  38. Correction: DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients
  39. DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients
  40. C syndrome - what do we know and what could the future hold?
  41. Case report of a child bearing a novel deleterious splicing variant in PIGT
  42. Pro-osteoporotic miR-320a impairs osteoblast function and induces oxidative stress
  43. Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types
  44. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study
  45. Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density
  46. The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring-Opitz Syndrome
  47. A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome
  48. Expression profiling of microRNAs in human bone tissue from postmenopausal women
  49. Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease
  50. Erratum to: MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones
  51. Involvement of Gaucher Disease Mutations in Parkinson Disease
  52. GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates
  53. A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes
  54. New murine Niemann-Pick type C models bearing a pseudoexon-generating mutation recapitulate the main neurobehavioural and molecular features of the disease
  55. Correction: Stereodivergent synthesis of right- and left-handed iminoxylitol heterodimers and monomers. Study of their impact on β-glucocerebrosidase activity
  56. Stereodivergent synthesis of right- and left-handed iminoxylitol heterodimers and monomers. Study of their impact on β-glucocerebrosidase activity
  57. The Spectrum of Niemann-Pick Type C Disease in Greece
  58. MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones
  59. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes
  60. Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks
  61. Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture
  62. EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome
  63. Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases
  64. CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss
  65. The Spectrum of Krabbe Disease in Greece: Biochemical and Molecular Findings
  66. Síndrome cardiofaciocutáneo, un trastorno relacionado con el síndrome de Noonan: hallazgos clínicos y moleculares en 11 pacientes
  67. Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations
  68. A broad spectrum of genomic changes in latinamerican patients with EXT1/EXT2-CDG
  69. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
  70. Cholesterol Regulates Syntaxin 6 Trafficking at trans-Golgi Network Endosomal Boundaries
  71. Genetic Analysis of High Bone Mass Cases from the BARCOS Cohort of Spanish Postmenopausal Women
  72. Antisense Mediated Splicing Modulation For Inherited Metabolic Diseases: Challenges for Delivery
  73. Glucocerebrosidase Enhancers for Selected Gaucher Disease Genotypes by Modification of α-1-C-Substituted Imino-D-xylitols (DIXs) by Click Chemistry
  74. Analyses ofRANKandRANKLin the Post-GWAS Context: Functional Evidence of Vitamin D Stimulation Through aRANKLDistal Region
  75. Description of extreme longevity in the Balearic Islands: Exploring a potential Blue Zone in Menorca, Spain
  76. Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies
  77. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
  78. Niemann-Pick type C disease: a novelNPC1mutation segregating in a Greek island
  79. Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas
  80. Characterisation of two deletions involving NPC1 and flanking genes in Niemann–Pick Type C disease patients
  81. A Novel Nonsense Mutation of the EXT1 Gene in an Argentinian Patient with Multiple Hereditary Exostoses
  82. COL1A1haplotypes and hip fracture
  83. Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
  84. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
  85. Identification and functional analyses of CBS alleles in Spanish and Argentinian homocystinuric patients
  86. Molecular characterization of a new deletion of the GBA1 gene due to an inter Alu recombination event
  87. Generation of a Human Neuronal Stable Cell Model for Niemann-Pick C Disease by RNA Interference
  88. Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles
  89. Molecular analysis of 30 Niemann-Pick type C patients from Spain
  90. Present and future of antisense therapy for splicing modulation in inherited metabolic disease
  91. Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency
  92. Perinatal lethal form of Gaucher disease. Clinical and molecular characterization of a Greek case
  93. Antisense oligonucleotide treatment for a pseudoexon-generating mutation in theNPC1gene causing Niemann-Pick type C disease
  94. Identification and characterization ofSMPD1mutations causing Niemann-Pick types A and B in Spanish patients
  95. Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures
  96. Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease
  97. A Haplotype-Based Analysis of theLRP5Gene in Relation to Osteoporosis Phenotypes in Spanish Postmenopausal Women
  98. Maroteaux–Lamy syndrome: Functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene
  99. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: The GENOMOS study
  100. Large-Scale Analysis of Association Between <emph type="ital">LRP5</emph> and <emph type="ital">LRP6</emph> Variants and Osteoporosis
  101. An evolutionary and structure‐based docking model for glucocerebrosidase–saposin C and glucocerebrosidase–substrate interactions—Relevance for Gaucher disease
  102. Recent Patents Relating to siRNAs and Therapeutic Strategies for Genetic Diseases
  103. Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H;H255Q] double mutant allele
  104. SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing
  105. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women
  106. Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients
  107. Promoter 2 -1025 T/C Polymorphism in the RUNX2 Gene Is Associated with Femoral Neck BMD in Spanish Postmenopausal Women
  108. Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux–Lamy syndrome) patients, including 9 novel mutations
  109. A CBS haplotype and a polymorphism at the MSR gene are associated with cardiovascular disease in a Spanish case–control study
  110. Identification of a novel pseudodeficiency allele in theGLB1gene in a carrier of GM1 gangliosidosis
  111. Bone Mass of a 113-Year-Old Man
  112. Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America
  113. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures
  114. RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: A preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases
  115. COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women
  116. Haplotypes Defined by Promoter and Intron 1 Polymorphisms of theCOLIA1Gene Regulate Bone Mineral Density in Women
  117. The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis
  118. Homozygosity for the double D409H+H255Q allele in type II Gaucher disease
  119. High prevalence ofCBS p.T191M mutation in homocystinuric patients from Colombia
  120. Functional assays testing pathogenicity of 14 cystathionine-beta synthase mutations
  121. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies
  122. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients
  123. Clinical and mutational characterization of three patients with multiple sulfatase deficiency: Report of a new splicing mutation
  124. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: Effect of the E326K change in neonatal and classic forms of the disease
  125. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity
  126. A folate-rich diet is as effective as folic acid from supplements in decreasing plasma homocysteine concentrations
  127. Differential Genetic Effects of <EMPH TYPE="ITAL">ESR1</EMPH> Gene Polymorphisms on Osteoporosis Outcomes
  128. Expression and functional characterization of human mutant sulfamidase in insect cells
  129. Two successful pregnancies in pyridoxine-nonresponsive homocystinuria
  130. Functional analysis of 13GBAmutant alleles identified in Gaucher disease patients: Pathogenic changes and “modifier” polymorphisms
  131. Unsuccessful chimeraplast strategy for the correction of a mutation causing Gaucher disease
  132. Spectrum of CBS mutations in 16 homocystinuric patients from the Iberian Peninsula: High prevalence of T191M and absence of I278T or G307S
  133. Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments
  134. Two New Single-Nucleotide Polymorphisms in the COL1A1 Upstream Regulatory Region and Their Relationship to Bone Mineral Density
  135. New Insights into the Origin of the Gaucher Disease-Causing Mutation N370S: Extended Haplotype Analysis Using the 5GC3.2, 5470 G/A, and ITG6.2 Polymorphisms
  136. Mutation and haplotype analyses in 26 Spanish Sanfilippo syndrome type A patients: Possible single origin for 1091delC mutation
  137. Homocysteine and the MTHFR 677C→T allele in premature coronary artery disease. Case control and family studies
  138. A New Gene–Pseudogene Fusion Allele Due to a Recombination in Intron 2 of the Glucocerebrosidase Gene Causes Gaucher Disease
  139. Gaucher Disease: The N370S Mutation in Ashkenazi Jewish and Spanish Patients has a Common Origin and Arose Several Thousand Years Ago
  140. Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.
  141. A new autosomal recessive retinitis pigmentosa locus maps on chromosome 2q31-q33.
  142. Mutation 1091delC is highly prevalent in Spanish Sanfilippo syndrome type A patients
  143. Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analyses
  144. A novel mutation in exon 17 of the ?-subunit of rod phosphodiesterase in two RP sisters of a consanguineous family
  145. Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation.
  146. Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families
  147. Gaucher disease in Spanish patients: Analysis of eight mutations
  148. Homozygous tandem duplication within the gene encoding the β-subunit of rod phosphodiesterase as a cause for autosomal recessive retinitis pigmentosa
  149. Genetic fine localization of the arrestin (S-antigen) gene 4 cM distal from D2S172
  150. Identification of positive and negative regulatory elements involved in the retinoic acid/cAMP induction of Fgf-3 transcription in F9 cells
  151. Starvation enhances lipoprotein lipase activity in the liver of the newborn rat